熱門資訊> 正文
BNB Plus获得120万美元订单;股价上涨超过5%
2026-01-05 21:23
- BNB Plus (BNBX) announced on Monday that it has received a $1.2 million order for LineaDNA, representing the largest LineaDNA order in company history.
- The order was placed by a global manufacturer of in vitro diagnostics (IVDs) under an existing supply agreement. The company has previously announced LineaDNA purchases by this customer, including a $600,000 follow-on order in July 2025.
- Inclusive of its recent $1.2 million order, the company expects to ship over $1.5 million of LineaDNA to customers in the IVD and biotherapeutic markets in the first half of calendar year 2026.
- BNBX +5.40% premarket to $1.56.
- Source: Press Release
More on Applied DNA Sciences
- Seeking Alpha’s Quant Rating on Applied DNA Sciences
- Financial information for Applied DNA Sciences
推薦文章
美股機會日報 | 凌晨3點！美聯儲將公佈1月貨幣政策會議紀要，納指期貨漲近0.5%；13F大曝光！巴菲特連續三季減持蘋果
美股機會日報 | 阿里發佈千問3.5！性能媲美Gemini 3；馬斯克稱Cybercab將於4月開始生產
港股周報 | 中國大模型「春節檔」打響！智譜周漲超138%；鉅虧超230億！美團周內重挫超10%
一周財經日曆 | 港美股迎「春節+總統日」雙假期！萬億零售巨頭沃爾瑪將發財報
從軟件到房地產，美國多板塊陷入AI恐慌拋售潮
Meta計劃為智能眼鏡添加人臉識別技術
危機四伏，市場卻似乎毫不在意
財報前瞻 | 英偉達Q4財報放榜在即！高盛、瑞銀預計將大超預期，兩大關鍵催化將帶來意外驚喜？
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
